1-6 of 6
Yeow-Tee Goh, MBBS, MD
Close
Sort by
Journal Articles

Asciminib, a Specific Allosteric BCR-ABL1 Inhibitor, in Patients with Chronic Myeloid Leukemia Carrying the T315I Mutation in a Phase 1 Trial

Delphine Rea, MD, Fabian Lang, MD, Dong-Wook Kim, MD PhD, Jorge E. Cortes, MD, Timothy P. Hughes, MDMBBS,FRACP,FRCPA, Hironobu Minami, MD PhD, Massimo Breccia, MD, Daniel J. Deangelo, MD, Andreas Hochhaus, MD, Moshe Talpaz, MD, Yeow Tee Goh, MBBS,MD, Philipp le Coutre, MD, Michael W. Deininger, MD PhD, Gabriel Etienne, MD PhD, Manu Sondhi, MD PhD, Kaushal Mishra, PhD, Paola Aimone, MD, Janet Ng-Sikorski, PhD, Michael J. Mauro, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 792.
https://doi.org/10.1182/blood-2018-99-113609
Published: 2018
Journal Articles

Impact of Incomplete Cycles and Dose Attenuation of Rituximab-Bendamustine on Survival Outcomes in Low-Grade Non-Hodgkin Lymphomas

Yunxin Chen, MBBS, Chandramouli Nagarajan, Nicholas Francis Grigoropoulos, Shin-Yeu Ong, MD, Kit Yan Loh, Allan Zhi Kai Goh, Yeow Tee Goh, MBBS, MD, Yuh Shan Lee, FRCPath, MRCP, MBBS
Journal: Blood
Blood (2018) 132 (Supplement 1): 4165.
https://doi.org/10.1182/blood-2018-99-112732
Published: 2018
Journal Articles

Overall Survival (OS) Benefit of Oral Ixazomib in Combination with Lenalidomide and Dexamethasone (IRd) Vs Lenalidomide and Dexamethasone (Rd) in Asian Patients (pts) with Relapsed and/or Refractory Multiple Myeloma (RRMM): Pooled-Analysis from the Tourmaline-MM1 and the China Continuation Studies

Weijun Fu, MD PhD, Jin Lu, Jie Jin, MD PhD, Yan Xu, MD, Depei Wu, Dao-bin Zhou, MD, Xiaoyan Ke, Xin Du, MD PhD, Xiequn Chen, MD PhD, Wee Joo Chng, MB ChB, PhD FRCP(UK), FRCPath, FAMS, Kihyun Kim, MD PhD, Junmin Li, MD PhD, Jae Hoon Lee, MD PhD, Jing Liu, PhD, Yeow Tee Goh, MBBS, MD, Kwang-Wei Wu, MD, Hui Wang, MD, Guohui Liu, PhD, Tomas Skacel, MD PhD, Hui Wan, MD PhD, Deborah Berg, RN, MSN
Journal: Blood
Blood (2018) 132 (Supplement 1): 5637.
https://doi.org/10.1182/blood-2018-99-116844
Published: 2018
Journal Articles

Prognostic Value of the Novel Mucosal Associated Lymphoid Tissue Prognostic Index (MALT-IPI) in Marginal Zone Lymphoma (MZL) Cases

Hian Li Esther Chan, MBBS, Liang Piu Koh, MBBS, MRCP, Vanessa CL Chong, Xin Liu, Sanjay De Mel, Joanne Shu Xian Lee, MBBS, MRCP, Anand Jeyasekharan, Suk Teng Chin, Soon Thye Lim, MBBS, MRCP, FAMS, Miriam Tao, MBBS, FAMS, FHKAM, FHKCP, MRCP, Richard Quek, Mohamad Farid, MBBS, MRCP (UK), Yuh Shan Lee, Daryl Tan, MBBS, MRCP, Chandramouli Nagarajan, Nicholas Francis Grigoropoulos, Colin Phipps Diong, Yeow Tee Goh, MBBS,MD, Tiffany Tang, MBBS, MRCP, Yen-Lin Chee, MBBS, MRCP, FRCPath, Michelle Poon, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 2885.
https://doi.org/10.1182/blood-2018-99-118364
Published: 2018
Journal Articles

Second-Line Bosutinib in Patients with Chronic Phase Chronic Myeloid Leukemia (CP CML) Resistant or Intolerant to Prior Imatinib: An 8-Year Update

Tim H. Brümmendorf, MD, Carlo Gambacorti-Passerini, MD, Dong-Wook Kim, MD PhD, Yeow Tee Goh, MBBS,MD, Iryna Dyagil, MDPhD, Katia B Pagnano, MD, Árpád Bátai, MD, Anna G Turkina, Prof., MD, Jean M. Aguiar, RN, Eric Leip, PhD, Jorge E. Cortes, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 900.
https://doi.org/10.1182/blood.V130.Suppl_1.900.900
Published: 2017
Journal Articles

Nilotinib Lowers the Incidence of BCR-ABL Mutations and Improves the Molecular Response Kinetics Compared with Imatinib in Patients (Pts) with Newly Diagnosed Chronic Myeloid Leukemia (CML).

Andreas Hochhaus, MD, Giuseppe Saglio, MD, PhD, Richard A. Larson, MD, Dong-Wook Kim, MD, PhD, Ian W. Flinn, MD, PhD, Yeow-Tee Goh, MBBS, MD, Pedro Enrique Dorlhiac-Llacer, MD, Kimmo Porkka, MD, PhD, Mineo Kurokawa, MD, PhD, Carmino DeSouza, MD, PhD, Yaping Shou, MD, PhD, Neil J. Gallagher, MD, PhD, Ariful Haque, Hagop Kantarjian, MD, Timothy P. Hughes, MD, MBBS
Journal: Blood
Blood (2010) 116 (21): 3431.
https://doi.org/10.1182/blood.V116.21.3431.3431
Published: 2010